XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The Company recorded the following revenues for the three and nine months ended September 30, 2024 and 2023 (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
ORLADEYO:
U.S.$103,112 $75,268 $278,987 $208,934 
Outside of U.S.13,207 10,416 34,487 26,173 
Total ORLADEYO116,319 85,684 313,474 235,107 
Other revenues766 1,058 5,704 2,904 
Total revenues$117,085 $86,742 $319,178 $238,011 
ORLADEYO revenues represent total revenues from product sales, collaborative revenues and royalties. Other revenues primarily relate to the Company’s product sales and royalties for peramivir.